420 with CNW — Report Shows Patients in Texas Lack Access to Medical Cannabis

According to a recent report by the Texas Department of Public Safety (DPS), further actions should be taken by the state to increase accessibility to medical cannabis. The report focuses on Texas’ Compassionate Use Program (CUP), analyzing its effectiveness in providing patients across the state with reasonable access to treatment.

The findings highlight that Texas’ vast size creates specific challenges for both dispensaries and patients. According to Goodblend senior director of government relations, Jervonne Singletary, the main problem dispensaries encounter is logistics. Everything must be obtained from the pickup location, which functions as a retail location, and any unsold or uncollected items must be returned to the main hub in Austin, Texas, at the end of the day.

In the newly released 70-page DPS report, a third-party assessment was conducted to evaluate the CUP and suggest improvements. One of the most important findings in the report is the need for better access to medical cannabis for patients across Texas.

Nico Richardson, CEO of Texas Original, also underlined the necessity of tightening rules, saying, “Before thinking about expanding the number of new licenses, you need to address the regulatory framework of the current system. Overreliance on a small number of operators is unsustainable.” When CUP debuted in 2015, Texas Original was one of the first three businesses granted a license to conduct business in the state.

Richardson cautions against assuming that the issue would be resolved by merely allowing more dispensaries, particularly in underprivileged areas throughout the state. He makes the point that adding additional operators without changing the regulatory framework would make it harder for companies to survive, especially in smaller areas, and ultimately would not increase access.

Another significant issue raised in the report is the growing trend of patients turning to the hemp market for alternatives, such as delta 8 products. These products remain largely unregulated in Texas, which creates potential risks for consumers. Singletary believes this is an unintended consequence of current regulations, noting, “I don’t think the Texas legislature meant to create this situation with such easy access to hemp products.”

The unregulated hemp market has raised concerns among licensed dispensaries, as Richardson points out: “We’re regulated as if we’re handling hazardous materials like enriched plutonium, and it’s no longer reasonable.” He, along with other operators, believes that Texas needs to rethink its regulations to ensure the program can adequately serve patients.

As of now, more than 66,000 patients have enrolled in the program since its inception. However, the DPS report clarifies that this number doesn’t necessarily reflect active participants.

The data indicating that patients in Texas have limited access to medical marijuana products is likely saddening to industry actors such as Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) which believe that patients who want to try medical cannabis products in jurisdictions where enabling laws exist shouldn’t unduly be limited from accessing products legally.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Research Says Most Americans Distrust Government as Cannabis Information Source

According to a recent study, many American adults tend to obtain information about cannabis not from government or medical resources but rather from friends and family. The study, which included a nationally representative sample of 1,161 participants, highlighted that government websites were the least preferred source for marijuana-related information, accounting for just 4.7% of respondents. Health providers were slightly more popular, with 9.3% citing them as a source. Interestingly, budtenders who provide guidance in cannabis dispensaries were at 8.6%.

In contrast, the leading sources of cannabis information were family and friends, with 35.65%, closely followed by websites at 33.7%. Notably, individuals using medical marijuana were more likely to cite healthcare professionals as a source of information compared to nonmedical users — 16.4% versus 5.2%, respectively.

The study points to a growing trend of liberalizing marijuana policies across the United States. It suggests that the potential shift in cannabis classification from schedule 1 to 3 of the Controlled Substances Act (CSA) could have widespread implications for public health. The authors of the paper emphasize the need for better education for healthcare providers on marijuana-related topics and careful management of government communications regarding cannabis.

Paul Armentano, deputy director of NORML, commented on the findings, noting that cannabis consumption is a longstanding practice that is not going to diminish. He emphasized that government agencies and healthcare providers should deliver accurate information about marijuana. Historically, government sources have either exaggerated or misrepresented the facts about cannabis and its consequences, which has contributed to the public’s skepticism regarding their credibility as reliable information sources.

Armentano also stressed that healthcare providers must remain updated on marijuana-related trends and research and should engage with their patients about cannabis just as they would with any other health-related behavior that could influence their patients’ well-being.

The authors of the study highlighted that the lack of adequate training for physicians may worsen the spread of misinformation regarding marijuana. Previous surveys and studies indicate that many healthcare professionals seek more relevant training, particularly during their medical education. Alarmingly, only 9% of medical schools in 2016 had specific courses on medical marijuana.

Among the surveyed individuals, 27% reported using cannabis within the past year. These individuals were more inclined to gather information from a variety of sources, except for government sites and mainstream media articles.

The study was published in the “Cannabis Research Journal” and received funding support from the National Institute on Drug Abuse.

It isn’t surprising that Americans prefer to obtain their cannabis information from industry actors such as Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED) since many state and federal authorities seem biased against marijuana. As long as those biases persist, the population could keep distrusting anything that the authorities say about marijuana.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Nebraska Officials Question Voter Signatures in Bid to Thwart Medical Marijuana Measure

Nebraska’s top election official and the state’s chief prosecutor are raising concerns about the validity of most signatures gathered for two medical marijuana petitions set to appear on the ballot this November. Mike Hilgers, Nebraska’s attorney general, who filed a legal motion on behalf of Bob Evnen, secretary of state, stated that inquiries are still being conducted to determine whether the 49,000-plus confirmed signatures on these petitions are authentic.

With early voting already underway on whether to legalize or regulate medical cannabis, Evnen and Hilger are urging the court to verify the total number of valid signatures and potentially nullify the election results if enough legitimate signatures are not confirmed.

In response, Nebraskans for Medical Cannabis criticized the state’s policies, stating that it is alarming that the state is attempting to silence Nebraskans based on largely speculative legal issues.

The legal filing accuses petition circulators of fraud or other misconduct in 72 of Nebraska’s 93 counties. Hilgers’ office claims that three notaries acted as both circulator and notary on an unspecified number of petitions, while six others notarized documents without witnessing the signatures in person, as required.

A total of eight notaries have been accused of misconduct. If the signatures collected by these individuals are disqualified, it could potentially void about 49,000 signatures on both the legalization and regulatory petitions.

Additionally, four circulators are accused of fraudulent activities, though the filing doesn’t specify the exact nature of the fraud. In total, about 656 signatures on each petition are at risk of being disqualified due to alleged fraud.

Hilgers argued that the burden of proving the signatures’ validity should fall on the petition sponsors, stating that when fraud or misconduct is discovered, any associated signatures lose their presumption of validity. His office is asking the court to take an even tougher stance than a 1919 state Supreme Court ruling that nullified signatures tied to fraudulent circulators during a referendum on women’s suffrage.

The investigation points to more than 30 people suspected of wrongdoing, including high rates of signature rejections. One sponsor involved is Crista Eggers, campaign manager for Nebraska Families 4 Medical Marijuana. As of now, no additional charges have been filed against any other circulators or notaries connected to the cannabis petitions.

This marks the third attempt by Nebraskans for Medical Cannabis to get the measure on the ballot. The organization’s first effort in 2020 was blocked by the state Supreme Court, and in 2022, the group failed to gather enough signatures. While several measures will appear on the Nov. 5 ballot this year, Evnen and Hilgers are focusing their scrutiny solely on the medical cannabis initiatives.

These efforts to block the passage of laws legalizing medical or recreational marijuana aren’t new. Companies such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) have seen similar issues arise in different markets, but the reform movement scores gains sooner or later.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Shows Teen Marijuana Users Have Poorer School Outcomes

According to a recent examination of the existing data, teenagers who use marijuana typically do poorly academically. The JAMA Pediatrics study analyzed information from 63 different studies involving nearly 440,000 adolescents.

The findings revealed that marijuana use during teenage years is likely associated with lower academic performance, decreased chances of finishing high school, less likelihood of enrolling in college or university, and a higher likelihood of dropping out of school and being frequently absent.

One significant point the researchers noted was that marijuana use among teens is widespread, with about 22% of high school students in the United States using cannabis at least once in the previous month. Another concern is that today’s marijuana is much stronger than it used to be, with THC levels increasing from 4% in 1995 to 14% in 2019.

The study also highlighted long-term effects, stating that heavy marijuana use during adolescence could lead to lasting changes in the brain’s structure. These changes might interfere with memory, cognitive function and attention span, all of which are critical to academic success.

To investigate the potential academic consequences, the team analyzed data from numerous studies that looked at cannabis use, school performance and even employment among young people. While not all the data was equally reliable, the researchers identified evidence — classified as “moderate certainty” — linking marijuana use with several negative outcomes. Specifically, they found that teens who used marijuana had:

39% higher chances of earning lower grades
50% lower odds of obtaining a high school certificate
28% less likelihood of attending university
31% decreased chance of earning a post-secondary degree
more than twice as likely to drop out of high school
more than twice as likely to miss school often

While the research team also found some evidence, though weaker, suggesting marijuana use could be tied to unemployment, the risks generally increased the more frequently a teen used the drug. Starting at an early age (before or around 16) also seemed to worsen the academic impact.

Although the findings suggest a strong link between marijuana use and poor school outcomes, the researchers acknowledged that they couldn’t definitively prove marijuana is the direct cause. For instance, teens struggling with other substance-use problems or mental-health concerns might be more likely to use marijuana and face challenges in school. However, the researchers adjusted their results to account for such factors.

One thing is clear: As marijuana becomes more accepted and decriminalized in various parts of the world, its use among teenagers is on the rise. U.S. national data suggests that more than three million teens aged between 12 and 17 years of age had used marijuana in the past year — more than any other illegal drug.

Given these trends, the researchers emphasized the urgent need for effective programs to prevent early marijuana use and protect youth from the potential negative consequences.

The age-verification activities that licensed companies such as Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) implement contribute to restricting access to marijuana by minors, but much more needs to be done by all stakeholders to keep marijuana away from teens.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Report Says NY Marijuana Program Has Undergone Successful Moments, Growing Pains

New York authorities recently published a comprehensive report on the progress of the state’s cannabis legalization law, which was signed by former Governor Andrew Cuomo in 2021. The state’s cannabis management office (OCM) shared the document, outlining the advancements made toward achieving the law’s primary goals.

The outlined advancements include fostering equity and creating opportunities for groups that have been disproportionately impacted by marijuana prohibition, building a strong and thriving industry, and preserving the environment, among others.

Tremaine Wright, head of the state marijuana control board, stated, “This report demonstrates our dedication to transparency and equity. I’m proud of how far we’ve come in the last three years to create a strong foundation for New York’s marijuana industry. Our objective has always been establishing a just and equitable industry that addresses historical wrongs and forges ahead with new prospects.”

According to the report, the state has licensed 200 cannabis retail dispensaries, with more than 1,300 recreational cannabis business licenses issued in total. The report also noted that54.7% of the licenses have gone to applicants from economic and social equity backgrounds. Additionally, most cannabis users are now purchasing from legal sources. According to the report, 67% of consumers who used marijuana in the past year said they bought their products from licensed dispensaries.

Another significant result of the law is the expungement of marijuana-related criminal records. More than 200,000 convictions have already been sealed, while an additional 107,000 are awaiting the same process. Furthermore, the report confirms that no one in the state is currently incarcerated for marijuana-related offenses alone.

In terms of consumer habits, the report noted that as of 2022, 14.9% of New Yorkers 18 years of age and older used marijuana monthly, with 7% reporting daily use. In addition, 52% said they used cannabis for recreational purposes, while 13.5% were medical users. Meanwhile, 34.5% reported using cannabis for both medical and recreational purposes.

The enforcement section of the report emphasizes that enforcing cannabis laws is crucial to maintaining a level playing field for legal operators. The report highlights that enforcement protects the investments of legal entrepreneurs while holding those selling illegal and unsafe products accountable.

The report acknowledges the struggles faced during the market’s initial phase, such as delays in rolling out the market, leadership disputes and issues surrounding the cannabis social-equity fund. It states that there is still much to do, including refining data collection, improving customer service, educating consumers and tackling the illegal marijuana market. Nonetheless, the officials are upbeat about the potential success of the sector.

The progress that is being made in rolling out the adult-use marijuana program in New York State is being watched positively by the entire industry, including entities such as Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) that would like to see all adults who use marijuana obtaining it from a licensed source.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Survey Finds Difference in View of Chronic Pain Patients, Doctors on Medical Cannabis

If you suffer from chronic pain and think medical cannabis could help, your doctor may not always share the same opinion. A recent survey of individuals living in states with legalized medical cannabis revealed significant differences in opinions between patients and healthcare providers.

According to the survey, which included responses from 1,000 doctors and 1,600 chronic pain patients, 71% of patients felt the federal government should legalize cannabis. However, only 59% of doctors agreed with this view. The survey also showed that 64% of patients believed that medical marijuana should be covered by health insurance, while 51% of doctors supported this idea.

The divide became even more evident when discussing the legalization of recreational cannabis. Fifty-five percent of patients felt it should be legalized across the United States, but only 38% of doctors shared this view. According to Elizabeth Stone, the study’s lead author, patients with chronic pain were generally more in favor of policies that increased access to medicinal marijuana, while healthcare practitioners tended to favor policies that limited its availability.

Currently, the availability of recreational and medical cannabis varies greatly depending on the state. Medical marijuana is legal in 38 states and Washington, DC. Additionally, 23 of these states have legalized the substance for recreational use.

According to Stone, one of the reasons cannabis stands out is the regulatory environment. “Marijuana use for medical or recreational purposes may be lawful, or neither may be permitted at all depending on where you live,” she said.

The survey primarily focused on adults suffering from noncancer chronic pain lasting six months or longer, as well as primary care doctors and specific specialists. Interestingly, most patients who had previously used medical cannabis and potentially experienced relief supported expanded access. On the other hand, doctors who had never recommended cannabis for pain relief were more hesitant to support broader legalization efforts.

Despite differing views, both patients and doctors largely agreed on one thing: 70% of both groups believed that medical schools should educate future physicians about medical cannabis and its potential use in pain management.

“All of this indicates a need for further guidance on the use and effectiveness of marijuana for medical purposes,” Stone stated. Questions about which patients should be recommended medical marijuana and what forms, dosages or methods of use are most appropriate remain topics for future research and policy development.

Pointers to the answers to some of those questions can be gleaned by examining the data that entities such as TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) have collected over time regarding the different ways in which medical marijuana users use medicinal cannabis.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Newsom Signs Measure Authorizing Cannabis Cafes to Operate in California

California Governor Gavin Newsom approved a measure that will allow the operation of marijuana cafés, modeled after those in the Netherlands. The law is set to come into effect on Jan. 1, 2025, subject to local government approvals.

Last year, Governor Newsom vetoed a similar proposal from Assembly Member Matt Haney, which would have permitted California’s cannabis retailers to run full kitchens and host events. Newsom’s main concern at the time was the lack of adequate worker protections in the bill.

In his latest signing statement, he expressed support for Haney’s improvements to the current bill. These changes include protecting employees’ right to wear masks, with employers covering the costs, and requiring that workers be informed about the dangers of secondhand marijuana smoke. Newsom also stressed that businesses that fail to follow these safeguards will not be viewed favorably.

The marijuana café law might be the only reprieve for California’s cannabis industry for the time being. The governor’s proposed $291 billion budget for FY 2024–2025 doesn’t include any cuts to the fees or taxes imposed on cannabis businesses.

Just a day earlier, Newsom vetoed a bill, AB 1111, that sought to allow small cannabis producers to sell their products directly to users, citing concerns about its wide scope. Further, he stated that the measure’s eligibility criteria, which included most licensed cannabis growers, could potentially strain the state’s cannabis control department’s regulatory efforts and disrupt the existing retail licensing structure.

The veto has been met with disappointment from advocates within the cannabis industry, particularly those representing small growers. The Origins Council, which represents around 800 producers in the Emerald Triangle, voiced its frustration, noting that small businesses are essential to the sustainability and equity of California’s cannabis market.

The bill, had it been signed into law, would have permitted small farmers to sell up to $175,000 worth of cannabis products at approved events, starting in January 2026.

Over the past few weeks, marijuana industry groups and advocates, such as the Origins Council, Equity Trade Network and Supernova Women, pushed hard for Newsom’s approval through various campaigns.

Despite the veto, Newsom noted that he was open to considering a revised version of the bill next year that would be more narrowly focused. He underlined that future legislation should address the major issues that the cannabis sector is currently facing, such as increased access to legal cannabis products and competition from unregulated sources.

This authorization of cannabis cafes in California is likely to be followed by marijuana companies, including SNDL Inc. (NASDAQ: SNDL), because it could usher in a new dynamic within legal marijuana markets in different jurisdictions. This is because when California leads the way, other jurisdictions often take a leaf from what has worked in the Golden State.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Arkansas Disqualifies Medical Cannabis Amendment for November Poll

John Thurston, Arkansas secretary of state, has rejected a proposed amendment aimed at broadening access to medical cannabis. Thurston announced on Aug. 31, 2024, that the group advocating for the reform, Arkansans for Patient Access, had not gathered enough valid signatures to qualify for inclusion on the ballot.

The organization had been given an additional 30 days to collect more signatures but ultimately fell short of the required 90,074 valid signatures. According to Thurston, only 10,521 of the signatures collected throughout the extended period were verified as legitimate. When added to the previously accepted signatures, the total reached 88,040, falling short of the required threshold.

Issue 3, if approved, would have increased the list of medical ailments that can be treated with medical cannabis. Additionally, it would have simplified the licensing process for medical cannabis patients and allowed more healthcare providers to prescribe cannabis.

In response to Thurston’s announcement, the Arkansans for Patient Access released a statement expressing its dissatisfaction and plans to pursue legal action against the office of the Secretary of State. Officials from the organization argue that they submitted more than 150,000 signatures from all Arkansas counties, showcasing strong public backing for the amendment.

The group also claims that the exclusion of approximately 20,000 signatures gathered during the extended period was the result of an unfair, last-minute procedural change that undermines the democratic process.

The main point of contention is a particular requirement that the amendment’s sponsor sign the canvasser registration forms instead of a representative of the business that employs canvassers. This same issue also prevented another proposed change, related to abortion rights, from moving forward in the current election cycle.

Bill Paschall, a spokesperson for Arkansans for Patient Access, argued that the duty of filing canvasser registration documents can be delegated and cited a similar legal stance taken in a previous casino-related case.

While Issue 3 will still appear on this year’s November ballot, any votes cast for or against it will not be counted unless there is a legal resolution.

The conservative Family Council Action Committee hinted in a statement that there will be further litigation over the change. Jerry Cox, executive director of the committee, suggested that those supporting the amendment, which consists of major cannabis businesses in Arkansas and have invested nearly $2 million, would likely appeal to the state’s supreme court to overturn Thurston’s decision.

If this matter goes to the state’s highest court, it could attract the attention of a variety of industry and allied actors such as Innovative Industrial Properties Inc. (NYSE: IIPR) since the expansion of the medical cannabis program could bring full legalization one step closer in Arkansas. Full cannabis legalization has been seen to create broad economic opportunities for different industries and verticals.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Releases Report on Series of Acquisitions, Multiple Cannabis Licenses

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, is reporting on recent acquisitions and cannabis licenses associated with the acquisitions. According to the announcement, the new acquisitions and licenses, which will add $1.6 million to company assets for the third quarter, are designed to bolster the company’s cannabis portfolio globally and solidify its position as a leading force in the cannabis sector. According to the announcement, the licenses include seven produce, process and sell CBD licenses; seven produce, process and sell THC licenses; seven fabrication of products containing cannabis licenses; and two genetics licenses.

“The acquisitions we have made put Medcana in a position to succeed and ensure profitably,” said MedCana CEO Gabriel Diaz in the press release.

To view the full press release, visit https://cnw.fm/GDGLg

About Software Effective Solutions

Software Effective Solutions/MedCana is a holding company focused on developing companies in the agricultural technology and the cannabis industries. As MedCana moves forward with its expansion plans, the company remains committed to delivering on its promise of building a solid foundation for future growth of its holdings. For more information, visit the company’s website at www.MedCana.net.

NOTE TO INVESTORS: The latest news and updates relating to SWISF are available in the company’s newsroom at https://cnw.fm/SFWJ

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Five Highlights from US NASEM Report on Marijuana

Cannabis legalization has made significant progress in the United States, with more than one-half of the states allowing its use for medical or recreational purposes, or both. However, despite these developments, cannabis is still illegal at the federal level.

A recent report from the National Academies of Sciences, Engineering and Medicine (NASEM) highlights the growing divide between federal and state laws, which creates inconsistent policies and could pose risks to public health. Initially, state regulations focused on the business side of cannabis, such as revenue and sales, overlooking public health.

This has led to a situation where policymakers are now scrambling to catch up. The report stresses the importance of federal guidance and consistent national standards to regulate the quality and potency of cannabis, ensuring consumer safety.

Below are five key takeaways from the report:

Cannabis use surpasses alcohol consumption

As per the National Survey on Drug Use and Health, more American adults reported using cannabis nearly every day in 2022 than alcohol, which was the first time marijuana overtook alcohol in terms of frequent use.

During the past 30 years, the number of regular marijuana users has grown significantly, from fewer than a million people in 1992 to almost 18 million in 2022. As cannabis becomes legal in more states, it is easier for people to obtain, with about two-thirds of adults saying the substance is fairly easy to get.

Additionally, the cost of cannabis has decreased, particularly in terms of the cost per unit of THC, the compound responsible for cannabis’ psychoactive effects.

The potency of cannabis products is often undisclosed

Cannabis has progressively grown more THC-concentrated over time. Although smoking dried marijuana flower remains common, there’s been a surge in the popularity of vape oils, edibles and other products.

While some states limit THC levels in certain cannabis products, such as edibles, many other cannabis products remain unregulated. THC concentrations in products such as shatter, wax and dabs can range from 60% to 90%, according to Dr. Yasmin Hurd, head of the Addiction Institute at Mount Sinai.

These high-potency products increase the risk of overconsumption, contributing to more hospital visits and accidents.

Psychoactive hemp products are available in states where cannabis is illegal

Despite marijuana being classified as a schedule I drug under federal law, the 2018 Farm Bill legalized certain hemp-derived products. This has led to an influx of products containing substances, including delta-8 THC and CBD, some of which can still have psychoactive effects.

These hemp-based products are often sold even in states where cannabis remains illegal, though they are largely unregulated. Health officials have raised concerns about the safety of these products, and the report recommends closing this regulatory loophole.

Cannabis research faces significant obstacles

Studying cannabis remains a challenge due to its classification as a schedule I drug, which places strict limitations on researchers. These restrictions make it difficult to conduct studies on the health effects of cannabis.

Even agencies such as the White House Office of National Drug Policy are not permitted to research the impacts of cannabis legalization. The report recommends that Congress remove these barriers and support more extensive research.

Marijuana health risks are often overlooked amid growing public support

Many people view cannabis as less harmful since its legalization, yet awareness of its potential risks remains low. THC has been linked to increased risks of marijuana use disorder, psychosis and suicidal thoughts, especially when consumed in higher doses.

With pro-marijuana advertising becoming more widespread, especially among young adults, there is growing concern about the long-term effects.

The report advocates for public health initiatives to educate the public on the risks, especially targeting vulnerable groups, including children, pregnant women and seniors. Moreover, it calls for better training for marijuana retail staff to provide accurate information to consumers.

This report is likely to draw the interest of cannabis companies such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) because it contains numerous insights that can offer glimpses into the discussion points likely to shape future federal policy on marijuana.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com